Silybin Meglumine Mitigates CCl4-Induced Liver Fibrosis and Bile Acid Metabolism Alterations
These findings underscore SLB-M decreased inflammatory response, reconstructed BA homeostasis possibly by regulating key pathways, and gene expressions in BA metabolism.
Authors
- Zhenzhou Jiang (ORCID: https://orcid.org/0000-0002-0420-0822)
- Luyong Zhang (ORCID: https://orcid.org/0000-0003-1164-7371)
- Wen Zhao (ORCID: https://orcid.org/0000-0002-1330-2329)
- Zifan Wang (ORCID: https://orcid.org/0000-0003-3394-8060)
- Ming Jin (ORCID: https://orcid.org/0000-0002-3324-8948)
- Anqin Li (ORCID: https://orcid.org/0000-0001-6434-9488)
- Qinwei Yu (ORCID: https://orcid.org/0000-0002-0879-8024)
- Xue Fan (ORCID: https://orcid.org/0000-0001-6406-7245)
- Xiaoxin Liu (ORCID: https://orcid.org/0000-0001-6380-264X)
- Ninglin Xia
Institutions
- China Pharmaceutical University (CN)
- Guangdong Pharmaceutical University (CN)
Publication Details
- Journal
- Metabolites
- Published
- 2024-10-17
- DOI
- https://doi.org/10.3390/metabo14100556
- Citations
- 3
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 1.40